製品名:6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine-2,4-diol;2,2,2-trifluoroacetic acid

IUPAC Name:5H,6H,7H-pyrrolo[3,4-d]pyrimidine-2,4-diol; trifluoroacetic acid

CAS番号:2387597-16-0
分子式:C8H8F3N3O4
純度:95%+
カタログ番号:CM1017993
分子量:267.16

包装単位 有効在庫 価格(USD) 数量
CM1017993-10g in stock ƙȬ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2387597-16-0
分子式:C8H8F3N3O4
融点:-
SMILESコード:OC(=O)C(F)(F)F.OC1=NC(O)=C2CNCC2=N1
密度:
カタログ番号:CM1017993
分子量:267.16
沸点:
MDL番号:
保管方法:

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.

Related Products